266
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Smoking during Pregnancy: Changes in Mid-Gestation Angiogenic Factors in Women at Risk of Developing Preeclampsia According to Uterine Artery Doppler Findings

, , , , , & show all
Pages 50-59 | Published online: 18 Sep 2012

REFERENCES

  • Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol 1996; 144(9):881–889.
  • Rasmussen S, Irgens L. The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth 2006; 6:16.
  • Conde-Agudelo A, Athabe F, Belizán JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: A systematic review. Am J Obstet Gynecol 1999; 181(4):1026–1035.
  • England L, Zhang J. Smoking and risk of preeclampsia: A systematic review. Front Biosci 2007; 12:2471–2483.
  • England LJ, Grauman A, Qian C, . Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res 2007; 9(10):1005–1013.
  • Karumanchi A, Levine RJ. How does smoking reduce the risk of preeclampsia? Hypertension 2010; 55(5):1100–1101.
  • Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: Effects of cigarette smoking and snuff. Hypertension 2010; 55(5):1254–1259.
  • Meekins JW, Pijenborg R, Hanssens M, McFadyen IR, Van Asshe A. A study of placental bed spiral arteries and throphoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994; 101(8):669–674.
  • Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004; 95(9):884–891.
  • Maynard SE, Min JY, Merchan J, . Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5):649–658.
  • Levine RJ, Maynard SE, Qian C, . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672–683.
  • Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacós E. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31(3):303–309.
  • Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000; 57(3):207–213.
  • Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 2008; 21(8):943–947.
  • Levine RJ, Lam C, Qian C. CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355(10):992–1005.
  • Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt1 and PlGF: Response to cigarette smoke. Am J Obstet Gynecol 2007; 197(4):363.e1–e5.
  • Brown MA, Lindheimer MD, De Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20(1):IX–XIV.
  • Soothill PW, Bobrow CS, Holmes R. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol 1999; 13(4):225–228.
  • Llurba E, Carreras E, Gratacós E. Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int 2009; 2009:275613. doi:10.1155/2009/275613
  • Haddow JE, Knight GJ, Palomaki GE. Measuring serum cotinine to aid in smoking cessation during pregnancy and to enhance assessment of smoking-related fetal morbidity. In: Poswillo D, Alberman E, eds. Effects of Smoking on the Fetus, Neonate and Child. New York: Oxford University Press, 1992: 207–1004.
  • Jeyabalan A, Powers RW, Clifton RG, . Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS One 2010; 5(10):e13270.
  • Savvidou MD, Sotiriadis A, Kaihura C, Nicolaides KH, Sattar N. Circulating levels of adiponectin and leptin at 23–25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clin Sci 2008; 115(7):219–224.
  • Muller PR, James AH, Murtha AP, Yonish B, Jamison MG, Dekker G. Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester. Hypertens Pregnancy 2006; 25(3):183–192.
  • Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: A prospective study. Hypertension: a prospective study. Hypertension 2008; 51(4):1002–1009.
  • Cnattingius S, Mills JL, Yuen J, Eriksson O, Salonen H. The paradoxical effect of smoking in preeclamptic pregnancies: Smoking reduces the incidence but increases the rates of perinatal mortality, abruption placentae and intrauterine growth restriction. Am J Obstet Gynecol 1997; 177(1):156–161.
  • Newman MG, Lindsay MK, Graves W. Cigarette smoking and pre-eclampsia: Their association and effects on clinical outcomes. J Matern Fetal Med 2001; 10(1):166–170.
  • Pipkin FB. Genetics of Preeclampsia Consortium. Smoking in moderate/ severe preeclampsia worsens pregnancy outcome, but smoking cessation limits the damage. Hypertension 2008; 51(4):1042–1046.
  • McCowan LM, Dekker GA, Chan E, SCOPE consortium. Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: Prospective cohort study. BMJ 2009; 338:b1081.
  • Kvehaugen AS, Andersen LF, Staff AC. Antrhopometry and cardiovascular risk factors in women and offspring after pregnancies complicated by preeclampsia or diabetes mellitus. Acta Obstet Gynecol Scand 2010; 89:1478–1485.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.